ISMPP is pleased to share information about the 51 posters presented at its 14th Annual Meeting, plus recent ISMPP member presentations at MedComms Networking events. The Society encourages members to publish and present research and information related to publishing...
Carolyn Hustad, PhD, Merck & Co., Inc., Kenilworth, NJ In the last five years, an increasing number of pharmaceutical and biotech companies have joined forces to develop and commercialize new compounds or drug combinations rather than go it alone. This trend is...
Molly E. Hoke, PhD, ISMPP CMPP™ Data transparency is a frequently mentioned and is a passionately discussed topic of relevance to, and has implications for, any publications professional working today in the world of clinical trial data generation and dissemination....
2018 has been a great year for ISMPP meeting attendance! First, the European Meeting of ISMPP in January saw a 20% increase from 2017, with 303 attendees. Now, the 14th Annual Meeting of ISMPP flourished with 629 attendees, a 12% increase from the previous year’s 561...
Dear ISMPP Members, With the 14th Annual Meeting of ISMPP just behind us, I realize how quickly an “ISMPP-Year” flies by. Looking back, I’m greatly appreciative of the time, insights, efforts, and work contributed by so many colleagues that have culminated in key...
ISMPP Insider is an informational and educational service intended for ISMPP members and the broader medical communications community. It is not meant as a basis for individual companies to make policy and/or procedural decisions, which should be made in consultation with the company’s Legal and/or Compliance representatives. The articles in ISMPP Insider do not necessarily represent the views of ISMPP.
ISMPP will grant limited permission to use postings and articles in ISMPP Insider for personal and noncommercial use. Permission requests or questions should be directed to ISMPP (ismpp@ismpp.org).
